Literature DB >> 3284283

Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up.

P Tønnesen1, V Fryd, M Hansen, J Helsted, A B Gunnersen, H Forchammer, M Stockner.   

Abstract

The aim of this study was to examine any dose response effect of 2 and 4 mg nicotine gum (Nicorette) as well as the effect of the treatment in relation to a control group. One hundred seventy-two cigarette smokers were randomly allocated to group counselling and 2 mg- (n = 62) or 4 mg- (n = 54) nicotine chewing gum or to an "advice only" control group (n = 56). Six group meetings in a three month period were guided by physicians in groups of 10-12 members. The 4 mg gum was replaced by 2 mg after 4 weeks. The overall chemical verified success rate was significantly higher for the treatment group compared with the control group. The success rate for the gum group was 45.6% after three months versus 7.1% for the control group, 33.3% versus 3.7% after 12 months, and 27.2% versus 5.7% after 22 months, respectively (p less than 0.001). We could not demonstrate any significant dose response effect of 2 and 4 mg nicotine gum. The low dependent smokers had the best outcome. The subgroup of self-reported chronic bronchitis subjects had a significantly lower success rate than their healthy counterparts (p less than 0.002). Neither the p-nicotine level after smoking or chewing gum nor the difference between these two could predict the outcome. The gum p-nicotine after a week was only 37.1% for 2 mg and 64.3% for 4 mg of the corresponding smoking p-nicotine levels. Nicotine compensation was best for the high dependent smokers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284283     DOI: 10.1016/0306-4603(88)90021-4

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  14 in total

Review 1.  Nicotine therapy in smoking cessation. Pharmacokinetic considerations.

Authors:  N G Schneider
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 2.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

Review 3.  Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.

Authors:  N G Schneider; E Lunell; R E Olmstead; K O Fagerström
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 5.  How physicians can help their patients quit smoking. A practical guide.

Authors:  A V Prochazka; E J Boyko
Journal:  West J Med       Date:  1988-08

Review 6.  Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.

Authors:  Jean-François Etter; John A Stapleton
Journal:  Tob Control       Date:  2006-08       Impact factor: 7.552

Review 7.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  How effective is nicotine replacement therapy in helping people to stop smoking?

Authors:  J L Tang; M Law; N Wald
Journal:  BMJ       Date:  1994-01-01

Review 9.  Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).

Authors:  Bertrand Dautzenberg; Mitchell Nides; Jean-Luc Kienzler; Anne Callens
Journal:  BMC Clin Pharmacol       Date:  2007-10-08

10.  Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Authors:  Edward J Mills; Ping Wu; Dean Spurden; Jon O Ebbert; Kumanan Wilson
Journal:  Harm Reduct J       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.